Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 13,880,000 shares, a growth of 32.8% from the March 15th total of 10,450,000 shares. Based on an average trading volume of 2,730,000 shares, the days-to-cover ratio is […]
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in […]
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have received a consensus rating of “Buy” from the six research firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued a report on the […]
China Universal Asset Management Co. Ltd. acquired a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 7,369 shares of the company’s stock, valued at approximately $59,000. A number of other hedge funds and other institutional investors have also recently added […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) shares traded down 3.9% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $7.30 and last traded at $7.34. 347,488 shares were traded during trading, a decline of 87% from the average session volume of 2,708,183 shares. The stock had previously closed […]